Randomized controlled trial compares six-month with nine-month anti-tubercular therapy for uveitis, indicating treatment effectiveness is similar.
Six-month ATT is non-inferior to 9-month ATT for treating tubercular posterior uveitis, though it may vary between the different clinical phenotypes.
No takes yet. Share an insight, caveat, or question.
Abhishek et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: